SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Monday reported a loss of $27.7 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 33 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

The biotechnology company posted revenue of $165,000 in the period.

For the year, the company reported a loss of $142.4 million, or $1.73 per share. Revenue was reported as $4.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGM at https://www.zacks.com/ap/NGM

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News